Shareholder Vote

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C.  20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): April 22, 2021 PFIZER INC . (Exact name of registrant as specified in its charter) Delaware 1-3619 13-5315170 (State or other (Commission File (I.R.S. Employer jurisdiction of Number) Identification No.) incorporation)     235 East 42nd Street 10017 New York, New York (Zip Code) (Address of principal executive offices) Registrant’s telephone number, including area code: ( 212 ) 733-2323 Not Applicable (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the obligation of the registrant under any of the following provisions (see General Instruction A.2. below): ☐ Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2 (b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, $.05 par value PFE New York Stock Exchange 0.250% Notes due 2022 PFE22 New York Stock Exchange 1.000% Notes due 2027 PFE27 New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company     ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.      ☐ Item 5.07   Submission of Matters to a Vote of Security Holders (a) The Pfizer Inc. (the "Company") Annual Meeting of Shareholders was held on April 22, 2021. (b) Shareholders voted on the matters set forth below. 1.  The nominees for election to the Company’s Board of Directors set forth in Item 1 to the Company’s Proxy Statement filed with the U.S. Securities and Exchange Commission on March 12, 2021 were elected to hold office until the Company’s next Annual Meeting of Shareholders, based upon the following votes: Nominee Votes For  Votes Against Abstentions Broker non-vote Ronald E. Blaylock 3,552,128,581 75,310,205 17,769,916 872,247,240 Albert Bourla 3,403,798,711 212,217,144 29,192,847 872,247,240 Susan Desmond-Hellmann 3,602,587,186 27,007,655 15,613,861 872,247,240 Joseph J. Echevarria 3,067,343,922 551,543,052 26,321,728 872,247,240 Scott Gottlieb 3,604,408,886 24,247,147 16,552,669 872,247,240 Helen H. Hobbs 3,591,164,311 38,498,000 15,546,391 872,247,240 Susan Hockfield 3,606,052,119 24,001,809 15,154,774 872,247,240 Dan R. Littman 3,598,774,848 28,603,952 17,829,902 872,247,240 Shantanu Narayen 3,590,073,401 38,138,233 16,997,068 872,247,240 Suzanne Nora Johnson 3,477,324,059 151,820,880 16,063,763 872,247,240 James Quincey 3,588,511,169 40,095,580 16,601,953 872,247,240 James C. Smith 3,575,587,764 53,048,897 16,572,041 872,247,240 2.  The proposal to ratify the selection of KPMG LLP as the Company’s independent registered public accounting firm for the 2021 fiscal year was approved based upon the following votes: Votes for approval 4,291,626,166 Votes against 208,758,238 Abstentions 17,071,538 Broker non-votes n/a 3. The proposal to approve, on an advisory basis, the compensation of the Company's Named Executive Officers was approved based upon the following votes : Votes for approval 3,355,194,651 Votes against 258,664,414 Abstentions 31,349,637 Broker non-votes 872,247,240 4. The shareholder proposal regarding independent chair policy was not approved based upon the following votes: Votes for approval 1,347,236,928 Votes against 2,260,655,067 Abstentions 37,316,707 Broker non-votes 872,247,240 5. The shareholder proposal regarding political spending report was not approved based upon the following votes: Votes for approval 1,636,845,263 Votes against 1,829,127,739 Abstentions 179,235,700 Broker non-votes 872,247,240 6. The shareholder proposal regarding report on access to COVID-19 products was not approved based upon the following votes: Votes for approval 1,011,019,874 Votes against 2,562,817,160 Abstentions 71,371,668 Broker non-votes 872,247,240 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.   PFIZER INC.             Dated: April 26, 2021 By: /s/ Margaret M. Madden     Margaret M. Madden     Senior Vice President and Corporate Secretary     Chief Governance Counsel